Skip to main content

Table 1 Demographics in the different genotypes of the β2-adrenergic receptor.

From: Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of β2-adrenergic receptor polymorphisms

Genotype

n*

(% of all)

Age

mean ± SD

BMI

mean ± SD

Hypertension

n (% of n*)

Diabetes

n (% of n*)

Dyslipidemia

n (% of n*)

CHD

n (% of n*)

MI

n (% of n*)

All

429

55.2 ± 10.7

31.1 ± 5.6

258 (60.1)

74 (17.2)

211 (49.2)

55 (12.8)

27 (6.3)

Codon -47

        

   Cys/Cys

131 (24.0)

55.9 ± 11.3

30.8 ± 5.2

76 (58.0)

23 (17.6)

65 (49.6)

16 (12.2)

11 (8.4)

   Cys/Arg

195 (45.2)

55.1 ± 10.7

31.1 ± 6.0

119 (61.0)

36 (18.5)

91 (46.7)

25 (12.8)

6 (3.1)

   Arg/Arg

103 (30.5)

54.2 ± 9.7

31.5 ± 5.6

63 (61.2)

15 (14.6)

55 (53.4)

14 (13.6)

10 (9.7)

P

 

0.512

0.705

0.837

0.694

0.539

0.952

0.040

Codon 16

        

   Arg/Arg

59 (13.8)

57.0 ± 9.9

31.6 ± 6.0

34 (57.6)

12 (20.8)

30 (50.8)

6 (10.9)

6 (10.2)

   Arg/Gly

197 (45.9)

54.0 ± 11.1

31.1 ± 6.0

121 (61.4)

35 (17.8)

95 (48.2)

23 (11.7)

7 (3.6)

   Gly/Gly

173 (40.3)

54.7 ± 10.5

31.0 ± 5.0

103 (59.5)

27 (15.6)

86 (49.7)

26 (15.0)

14 (8.1)

P

 

0.347

0.790

0.854

0.684

0.924

0.507

0.084

Codon 27

        

   Gln/Gln

109 (25.4)

55.9 ± 11.0

31.5 ± 5.4

67 (61.5)

23 (21.1)

60 (55.0)

16 (14.7)

13 (11.9)

   Gln/Glu

202 (47.1)

56.0 ± 10.5

31.0 ± 6.0

117 (57.9)

33 (16.3)

88 (43.6)

24 (11.9)

7 (3.5)

   Glu/Glu

118 (27.5)

52.9 ± 10.5

30-9 ± 5.2

74 (62.7)

18 (15.3)

63 (53.4)

15 (12.7)

7 (5.9)

P

 

0.031

0.746

0.663

0.454

0.087

0.391

0.013

  1. Demographics of the study group (n = 429) and its subgroups with the different genotypes of the β2-adrenergic receptor polymorphisms.
  2. Statistical tests that revealed P-values below 0.1 are in bold. There were significantly lower rates for MI in heterozygous genotypes of Cys-47Arg and the Gln27Glu polymorphisms in spite of the significant older age in the Gln27Glu variant. In addition, there wass also a trend for a lower rate of MI in the heterozygous genotype of the Arg16Gly variation.
  3. BMI, body mass index; CHD, coronary heart disease; MI, myocardial infarction.